Non-Invasive Aesthetic Treatment Market

Market Overview

The global non-invasive aesthetic treatment market size was valued at USD 53.90 billion in 2021. It is projected to reach USD 194.87 billion by 2030, growing at a CAGR of 15.35% during the forecast period (2022-2030). 

Non-invasive aesthetic treatment is a medical practice that involves few or no incisions on the skin, leaving no visible marks afterward. These medical procedures are very safe and successful. Adults' increasing concern with appearance has resulted in a rise in demand for non-invasive aesthetic procedures recently. According to the American Society for Aesthetic Plastic Surgery (ASAPS), 3.8 million minimally invasive cosmetic procedures were performed on Americans aged 55 and over in 2018. This underlines the market in the nation's future excellent growth prospects.

Market Dynamics

Global Non-Invasive Aesthetic Treatment Market Drivers

Growing Beauty Consciousness among Consumers

Invasive surgeries are quickly being replaced with minimally invasive procedures. Due to several beauty ads run by major market players, awareness of minimally invasive procedures is rising. For instance, Allergan started a "Juvederm it" campaign in 2018 to promote its Juvederm hyaluronic acid lip filler. Compared to invasive surgeries, non-invasive aesthetic procedures provide shorter recovery times, less discomfort and surgical wounds, smaller incisions, quicker wound healing, and fewer problems. Additionally, compared to traditional surgical procedures, the currently available minimally invasive surgeries are more successful and yield superior results.

International Society of Aesthetic Plastic Surgery (ISAPS) estimated that 2,630,832 non-invasive treatments were carried out in the United States alone in 2019, out of 13,618,735 conducted globally. In addition, permanent cosmetic operations like fillers, implants, fat grafting, and lip enhancements are becoming more popular. The most common of them are fillers since they have a shallow risk of adverse effects and allergic responses and are readily tolerated by the body. Examples of fillers are hyaluronic acid and poly-L lactic acid. According to the same poll, the top and most popular non-invasive aesthetic procedures are photo rejuvenation, nonsurgical fat reduction, botulinum toxin fillers, and hyaluronic acid fillers.

Global Non-Invasive Aesthetic Treatment Market Restraints

Lack of Insurance Companies' Coverage

Private and public insurance programs do not always cover aesthetic operations. Reimbursement is not provided for procedures primarily designed to eliminate wrinkles, fat, hair, tattoos, extra skin, and liposuction for improving outward appearance. According to IRS rules in the United States, any cosmetic surgery or operation is not eligible for reimbursement. As a result, a patient's decision to receive the treatment is mainly determined by their capacity to pay for it.

However, patients may be reimbursed for required therapies as part of their ongoing medical care. These procedures include weight reduction surgery to lessen difficulties brought on by being overweight and facial reconstruction following an accident. The percentage of surgical procedures conducted for improving aesthetic appearance is higher than those supported by medical reasons. As a result, the market's total growth may be constrained by the bulk of procedures not being covered by reimbursement.

Global Non-Invasive Aesthetic Treatment Market Opportunities

Rising Population of Older Adults

The World Population Prospects 2019 report predicts that by 2050, one in six persons will be beyond the age of 65 worldwide, up from one in eleven in 2019. In addition, the number of individuals 65 and older worldwide was estimated at 703 million in 2019, and by 2050, that number is expected to double to 1.5 billion, according to figures released by the U.N.

India had a population of 1.36 billion in 2019, up from 942.2 million in 1994, and 6% of its people were 65 years of age or older, according to the United Nations Population Fund (UNFPA) State of the World Population 2019 report, which was published in April 2020. Eastern and Southeast Asia are predicted to contain nine out of the ten nations where the percentage of the old global population will increase by the most between 2019 and 2050. The growing population around the world is expected to create tremendous opportunities for the global market of non-invasive aesthetic treatment over the forecast period.

Regional Analysis

The global non-invasive aesthetic treatment market is bifurcated into four regions: North America, Europe, Asia-Pacific, and LAMEA. 

North America Dominates the Global Market

North America is the most significant shareholder in the global market of non-invasive aesthetic treatment and is anticipated to grow at a CAGR of 13.65% over the forecast period. In terms of market revenue for non-invasive aesthetic treatments in 2021, North America held the largest share at 36%. The rising incidence of skin cancer and other skin conditions, including eczema and rosacea, as well as the rising popularity of cosmetic operations, are some of the key drivers of market expansion in this area. The market is anticipated to grow as improved treatment alternatives, including laser treatments to improve one's visual appeal, become more widely used. In addition, growing aesthetic sensibility is another important factor driving this market's expansion in North America.

Europe is expected to grow at a CAGR of 15.60%, generating USD 51,060.61 million during the forecast period. The market's size is explained by the participation of advanced European economies like Germany and the U.K., which are significant market participants for non-invasive European non-invasive aesthetic procedures. With cutting-edge technologies and a solid infrastructure, Europe is one of the most developed regions in the world, leading to superior healthcare facilities and patient care. Due to the presence of trained experts and the increase in the elderly population, the region is anticipated to grow at a good pace throughout the projection period.

The region with the highest CAGR during the forecast period is the Asia-Pacific. Several factors influence market expansion in the Asia-Pacific region, including the high volume of aesthetic treatments performed annually in South Korea, Japan, and China, the availability of competent and qualified experts, and low procedure costs. Additionally, the region's growing workforce of professionals and high standard of living are driving up demand for aesthetic procedures. The rise of industries in the region has been primarily attributed to the increase in significant multinational corporations engaging in R&D in these regions. People are also becoming more aware of their appearance, particularly women, which is fueling the expansion of the Asia-Pacific market for non-invasive aesthetic treatment.

Latin America is predicted to be a lucrative market because there are more affordable options for cutting-edge aesthetic procedures than in North America and Europe. Brazil is a popular location for aesthetic treatment because of its expanding medical tourism industry and accessibility to cutting-edge therapies at reasonable prices. Additionally, the market is expanding due to strong foreign direct investment, disposable income, healthcare spending, advantageous reimbursement policies, and technology and medical developments.

Segmental Analysis

The global non-invasive aesthetic treatment market is segmented by procedure and end-user.

Based on procedure, the global market is bifurcated into skin rejuvenation and injectables.

The injectable segment is the highest contributor to the market and is expected to grow at a CAGR of 15.70% during the forecast period. Due to their FDA approval and safety for aesthetic usage, botulinum toxin and hyaluronic acid fillers are commonly used in procedures in nations including the United States, Brazil, Germany, and India. Additionally, they have excellent patient satisfaction and offer immediate results. About 10,610,748 injectable treatments involving calcium hydroxylapatite, poly-L-lactic acid, botulinum toxin, and hyaluronic acid fillers were performed globally in 2020.

The most common and in-demand fillers for non-invasive aesthetic enhancement are made of botulinum toxin. There are now only a handful of commercially available BNT-A products and one BNT-B product on the market. However, significant R&D expenditures to increase BNT's aesthetic applications are projected to drive market growth in the near term. Commercially available medications like Botox and Dysport have several therapeutic uses for treating primary axillary hyperhidrosis, blepharospasm, cervical dystonia, and aesthetic uses for minimizing glabellar wrinkles. Botox is currently gaining popularity in the aesthetics industry because dermatological professionals and experts have approved and advised it to improve facial appearance, reduce signs of aging, and treat frown lines and crow's feet.

This type of wrinkle filler, injected subcutaneously with a tiny needle to treat moderate to severe facial wrinkles and folds (nasolabial folds), marionette, and frown lines, comprises CaHA microspheres dispersed in an aqueous Carboxymethylcellulose (CMC) gel carrier. CaHA filler is biocompatible with human tissue and has long-lasting, semi-permanent adhesiveness. The injectable CaHA products RADIESSE, RADIESSE (+), and RADIESSE Lidocaine are a few commercially available options. Due to their synthetic nature and profound dermal effects, CaHA products will likely outlast natural collagen fillers and contribute to the market's growth.

With more people choosing this technique, skin rejuvenation is one of the beauty industry's most popular treatments. The most popular procedures for skin rejuvenation include laser resurfacing, chemical peels, dermabrasion, and microdermabrasion. Wrinkles, pigmentation, vascular issues, loss of skin tone, and dull skin are typical conditions that skin rejuvenation treats. One of the leading causes of a rise in the use of this approach is growing concern about visual appeal. According to the United States, approximately 997,245 laser skin resurfacing procedures will be carried out in 2020. Cutera, Inc.'s Enlighten picosecond nanosecond laser device enables skin rejuvenation in fewer sessions and offers more durable results.

Based on end-user, the global market is bifurcated into hospital/surgery centers, med Spa, traditional Spa, and HCP clinics.

The med spa segment owns the highest market share and is expected to grow at a CAGR of 16.75% during the forecast period. Aesthetic clinics and med spas are places where cosmetic procedures are carried out under the direction of qualified medical professionals. Med spas typically combine day spas with aesthetic medical offices to provide corrective medical skin care services and products. Injections for the face (dermal fillers, botulinum toxin), non-invasive body contouring (CoolSculpting, hot sculpting, butt/breast, etc.), skin rejuvenation (chemical peels, laser skin resurfacing, photorejuvenation, hydradermabrasion), laser hair removal, IPL hair removal, laser tattoo removal, and laser scar removal are among the procedures offered in med spas.

SBDC Net National Information Clearinghouse states that about 77,000 beauty salons are currently operating in the United States. Demographics, population growth, and rising personal income are just a few variables promoting market expansion. Effective marketing and repeat business are two main factors that influence the profitability of traditional spas. According to the same report, 50 major beauty salon owners are responsible for 15% of the industry's revenue in the United States. In addition, around 3,000 spa facilities, 74% of which are day spas, can be found in Canada, according to the Spa Industry Association of Canada (SIAC).

Recent Developments

• November 2022- Sisu Clinic, a doctor-led cosmetic medicine destination offering a comprehensive range of the most advanced, non-invasive beauty treatments worldwide, opened the doors to its first New York City location in the SoHo neighborhood.
• May 2020- Restylane Kysse, made by Galderma and containing hyaluronic acid, was approved by the Food and Drug Administration (FDA) of the United States. This product was designed to augment the lips and treat perioral rhytids.